Advertisement

Research Article Free access | 10.1172/JCI114004

Neuropeptide-Y. A peptide found in human coronary arteries constricts primarily small coronary arteries to produce myocardial ischemia in dogs.

M F Maturi, R Greene, E Speir, C Burrus, L M Dorsey, D R Markle, M Maxwell, W Schmidt, S R Goldstein, and R E Patterson

Experimental Physiology and Pharmacology Section, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892.

Find articles by Maturi, M. in: PubMed | Google Scholar

Experimental Physiology and Pharmacology Section, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892.

Find articles by Greene, R. in: PubMed | Google Scholar

Experimental Physiology and Pharmacology Section, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892.

Find articles by Speir, E. in: PubMed | Google Scholar

Experimental Physiology and Pharmacology Section, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892.

Find articles by Burrus, C. in: PubMed | Google Scholar

Experimental Physiology and Pharmacology Section, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892.

Find articles by Dorsey, L. in: PubMed | Google Scholar

Experimental Physiology and Pharmacology Section, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892.

Find articles by Markle, D. in: PubMed | Google Scholar

Experimental Physiology and Pharmacology Section, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892.

Find articles by Maxwell, M. in: PubMed | Google Scholar

Experimental Physiology and Pharmacology Section, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892.

Find articles by Schmidt, W. in: PubMed | Google Scholar

Experimental Physiology and Pharmacology Section, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892.

Find articles by Goldstein, S. in: PubMed | Google Scholar

Experimental Physiology and Pharmacology Section, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892.

Find articles by Patterson, R. in: PubMed | Google Scholar

Published April 1, 1989 - More info

Published in Volume 83, Issue 4 on April 1, 1989
J Clin Invest. 1989;83(4):1217–1224. https://doi.org/10.1172/JCI114004.
© 1989 The American Society for Clinical Investigation
Published April 1, 1989 - Version history
View PDF
Abstract

Neuropeptide-Y (NPY), a brain peptide, is located in the walls of human coronary arteries. This study assessed the effects of NPY on the coronary circulation in 40 chloralose-anesthetized, open-chest dogs. Intracoronary NPY (42 nmol over 5.2 min) caused a 39% reduction in coronary blood flow without changing heart rate or aortic pressure. To determine whether this vasoconstriction could produce ischemia, intramyocardial pH was measured in seven dogs (group I) and decreased from 7.45 +/- 0.06 to 7.37 +/- 0.06 pH units after NPY in the subendocardium (P less than 0.0002), and from 7.45 +/- 0.06 to 7.40 +/- 0.05 pH units (P less than 0.04) in the subepicardium of the infused zone. Left ventricular ejection fraction (LVEF), measured by radionuclide angiography, decreased from 0.52 +/- 0.08 to 0.42 +/- 0.12 U (n = 5, P less than 0.01) during NPY. NPY-induced vasoconstriction was also associated with ST-T wave changes on the electrocardiogram (ECG) in eight of nine other animals (group V). In another group of six dogs (group IV), the change in small vessel resistance accounted for 94% of the increase in total resistance, so that the primary vasoconstrictor effect of NPY was exerted on small coronary arteries. Thus, NPY, a peptide found in human coronary arteries, caused constriction of primarily small coronary arteries that was severe enough to produce myocardial ischemia as determined by ECG ST-T wave changes, and decreases in intramyocardial pH and LVEF in dogs.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

Version history
  • Version 1 (April 1, 1989): No description
Advertisement
Advertisement